Cantor Fitzgerald Maintains Price Target on MongoDB, Sees Atlas Usage Rebound
Management at MongoDB, Inc. (NASDAQ:MDB) remains optimistic about Atlas' potential for growth of more than 20%, even when enterprise agreements are expected to drop by a high single-digit percentage for the rest of the fiscal year.
Discussions with the CFO of MongoDB, Inc. (NASDAQ:MDB) revealed that Atlas usage had resumed its previous trends. This comeback is viewed as encouraging for the company's future growth. Moreover, according to Cantor Fitzgerald analysts, MongoDB's reference to a well-known AI client utilizing its platform alleviated worries regarding the company's strategic placement within the enterprise AI data stack.
MongoDB, Inc. (NASDAQ:MDB) offers a versatile database platform that includes enterprise-grade solutions, cloud-based services, and a free version for developers.
While we acknowledge the potential of MDB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
Read More: and
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Blink Charging, dfYOUNG Partner For Simplified EV Fleet Management
Blink Charging (NASDAQ:BLNK) announced a new partnership with logistics firm dfYOUNG on Monday to simplify EV fleet management and home charger installations for corporate sales teams across the U.S. The companies aim to streamline the EV transition by combining Blink's charging technology with dfYOUNG's fleet logistics expertise. As part of the collaboration, dfYOUNG will deliver and install pre-packaged, RFID-enabled Blink chargers at sales representatives' will handle around-the-clock customer support, while dfYOUNG oversees fleet operations, which include delivery tracking, job completion, safety checks, and regulatory compliance. The news comes as Blink Charging's stock has faced significant headwinds, plunging over 19% year-to-date. This decline is largely attributed to the company missing analyst revenue estimates for the past four consecutive quarters and EPS estimates for at least two quarters. The stock performance has also been impacted by the Trump administration's recent reversal of EV tax credits. The U.S. House of Representatives approved President Donald Trump's 'Big Beautiful Bill,' which terminates the $7,500 tax credit for new U.S.-made EVs, effective September 30, 2025. This policy change is expected to negatively affect the EV industry and its ecosystem, including companies like Blink Charging, with some automakers already increasing EV prices in response. Despite these challenges, Blink Charging has remained committed to unlocking value through strategic partnerships, acquisitions, and geographical expansions. Last Monday, Blink Charging expanded its partnership with Belgian real estate firm Group Bernaerts to boost EV charging infrastructure across Belgium. By the end of 2025, it plans to install at least 176 active chargers at Bernaerts-owned properties. The stock gained close to 13% after the update. Since the partnership was launched in 2022, the two companies have deployed 88 charging stations in Antwerp and Mechelen. As they accelerate their sustainability goals, they expect to double that number by the end of this year. On July 16, Blink Charging expanded its EV network in South Florida by installing Series 7 chargers at two Accesso-managed commercial properties. The move strengthens Blink's regional presence, bringing clean energy charging to high-traffic sites in Sunrise and West Boca Raton. On July 14, Blink Charging expanded its EV charging footprint by acquiring Zemetric, a Silicon Valley-based fleet-focused infrastructure firm. The deal brings Zemetric's leadership team, now filling key executive roles at Blink, together to accelerate innovation and global growth in smart fleet charging. On July 10, Blink Charging advanced its U.K. expansion by partnering with Axxeltrova to launch a £100 million fund for EV infrastructure growth. Under the deal, Axxeltrova will fund and own the chargers, while Blink installs, operates, and maintains them through its Blink Network. Price Action: BLNK shares are trading lower by 5.36% to $1.060 at last check Monday. Photo via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Blink Charging, dfYOUNG Partner For Simplified EV Fleet Management originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
15 minutes ago
- Yahoo
Delta Air Lines, Inc. (DAL) Expresses Confidence in Future Growth; Reaffirms Full-Year Earnings Guidance
Delta Air Lines, Inc. (NYSE:DAL), considered a cheaply priced stock and a top pick among analysts, is included in our list of the . Chris Parypa Photography / With strong free cash flow, margin discipline, and forward-thinking investments, Delta Air Lines, Inc. (NYSE:DAL) remains optimistic about its future growth outlook. In its earnings call, published on July 11, 2025, Delta Air Lines, Inc. (NYSE:DAL) maintained its full-year 2025 EPS guidance of $5.25 to $6.25, expecting $3 to $4 billion in free cash flow. This supports the company's plan to reduce its debt by $3 billion and increase its dividend by 25%. Meanwhile, the company's diversified, high-margin revenue segments now account for 66% of total revenue. This includes record co-branded card revenue from American Express, which is up 10% YoY. Furthermore, Delta Air Lines, Inc. (NYSE:DAL) eyes future growth with heavy investments in global expansion (e.g., WestJet and IndiGo partnerships), premium cabin growth, AI-powered revenue tools like Fetcherr, and customer experience enhancements such as Delta Concierge. With these growth strategies, Delta aims to broaden its margins and capitalize on evolving travel patterns. With its Airline and Refinery segments, Delta Air Lines, Inc. (NYSE:DAL) offers scheduled air transportation service for passengers and cargo. It is included in our list of cheap travel stocks. While we acknowledge the potential of DAL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and 10 Cheap Lithium Stocks to Buy According to Hedge Funds. Disclosure: None.
Yahoo
15 minutes ago
- Yahoo
Celcuity Stock Triples on Positive Breast Cancer Treatment Study
Shares of Celcuity (CELC) tripled to an all-time high after the biotech firm announced positive results in a late-stage study of its experimental treatment for adults with two kinds of breast cancer. The company reported primary endpoints were reached in the Phase 3 trial of gedatolisib, combined with two other drugs, palbociclib and fulvestrant, which it calls the "gedatolisib triple." It said the three together reduced the risk of disease progression or death by 76% compared to fulvestrant alone. A "gedatolisib double" combination of gedatolisib and fulvestrant cut risk of disease progression or death by 67% versus fulvestrant alone, also exceeding endpoints. The patients tested suffered from "hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA wild-type, locally advanced or metastatic breast cancer, following progression on, or after, treatment with a CDK4/6 inhibitor and an aromatase inhibitor." Dr. Sara Hurvitz, co-principal investigator of the trial, said to her knowledge, "we have not seen Phase 3 results in patients with HR-positive, HER2-negative advanced breast cancer before where there was a quadrupling of the likelihood of survival without disease progression relative to the study control." Dr. Igor Gorbatchevsky, Chief Medical Officer at Celcuity, added that the results showed gedatolisib could be a "transformative new medicine" for the treatment of those breast cancers. The company plans to submit a New Drug Application to the Food and Drug Administration (FDA) for gedatolisib in the fourth quarter. Celcuity shares, which entered the day up 5% this year, soared 210% less than an hour after the opening bell Monday. Read the original article on Investopedia Sign in to access your portfolio
